Claudia Schumacher
3PUBLICATIONS
34CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (3)
Sort by Publication Date:
|Feb 22, 2023
De-Escalated Neoadjuvant Trastuzumab-Emtansine With or Without Endocrine Therapy Versus Trastuzumab With Endocrine Therapy in HR+/HER2+ Early Breast Cancer: 5-Year Survival in the WSG-ADAPT-TP Trial.Nadia Harbeck, Ulrike A Nitz, Matthias Christgen
|Nov 28, 2022
Impact of RNA Signatures on pCR and Survival after 12-Week Neoadjuvant Pertuzumab plus Trastuzumab with or without Paclitaxel in the WSG-ADAPT HER2+/HR- Trial.Monika Graeser, Oleg Gluz, Claudia Biehl
|Jul 07, 2022
De-escalated Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer (TNBC): Impact of Molecular Markers and Final Survival Analysis of the WSG-ADAPT-TN Trial.Oleg Gluz, Ulrike Nitz, Cornelia Kolberg-Liedtke
Pageof 1
Frequent Collaborators
3 joint publications
Oleg Gluz
3 joint publications
Eva-Maria Grischke
3 joint publications
Monika Graeser
3 joint publications
Nadia Harbeck
2 joint publications
Helmut Forstbauer
2 joint publications
Michael Braun
2 joint publications
Jochem Potenberg
2 joint publications
Sherko Kümmel
2 joint publications
Bahriye Aktas
2 joint publications
Matthias Christgen
